Ailurus Bio logo

Ailurus Bio

Programming biology to automate and accelerate science.

17 employees · est. 2022 · London, United Kingdom

VS
NextRNA Therapeutics logo

NextRNA Therapeutics

Leading The Next Revolution of RNA-directed Therapeutics

8 employees · est. 2020 · Boston, United States

NextRNA Therapeutics is the older company (2022 vs 2020); Ailurus Bio is the larger of the two.

Side-by-Side Comparison

Ailurus Bio NextRNA Therapeutics
Founded
2022 2020 older
Headquarters
London, United Kingdom Boston, United States
Employees
17 larger 8
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Undisclosed Seed
Total Funding
Not tracked yet $18.60M
Funding Rounds
1 3
Services
PandaPure Protein Systems, Ailurus vec Expression Libraries, Construct Design and Building, Metabolic Engineering Development of lncRNA-based therapies, Research and development in cancer treatment, Biopharmaceutical innovation
Target Customers
Researchers, Biodevelopers, Synthetic Biologists, Life Science Companies, Biotechnology Firms, R&D Laboratories Patients with cancer, Healthcare providers, Pharmaceutical companies
Taxonomy
Synthetic Biology, Bioengineering, Biological Programming, Molecular Biology, AI Integration, Lab Automation, High-throughput Screening, Biocomputing, Cloud Biocomputation, Genetic Instruction Development, Biological Software, Strain Optimization, Protein Purification, Self-Driving Labs, Biocomputer Architecture RNA-directed Therapeutics, Long Non-coding RNAs, LncRNA Biology, Small Molecule Drugging, Oncology, Neuroscience, Computational Biology, Drug Discovery, Therapeutic Value, Cambridge Massachusetts, NcRNA Discovery, Disease-targeted Therapeutics, Biopharma Startup, LncRNA Expertise
Website
ailurus.bio nextrnatx.com
Ailurus Bio logo

About Ailurus Bio

Ailurus Bio, founded in 2022 and headquartered in the United Kingdom, is a trailblazer in the Biopharma, Biotechnology, and Life Sciences sectors. The company's mission, encapsulated by its slogan "Programming biology to automate and accelerate science," revolves around transforming lab-grown cells...

NextRNA Therapeutics logo

About NextRNA Therapeutics

NextRNA Therapeutics is at the forefront of RNA-directed therapeutics, based in Boston and founded in 2020. The company is revolutionizing the realm of biotechnology by targeting long non-coding RNAs (lncRNAs) with small molecules, primarily in the fields of oncology and neuroscience. Leveraging...

We will tell you when either one moves

BounceWatch watches Ailurus Bio and NextRNA Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ailurus Bio and NextRNA Therapeutics — by email.

Frequently Asked Questions

Ailurus Bio — Programming biology to automate and accelerate science.. NextRNA Therapeutics — Leading The Next Revolution of RNA-directed Therapeutics . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ailurus Bio has raised undisclosed funding while NextRNA Therapeutics has raised $18.60M.
Ailurus Bio and NextRNA Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ailurus Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ailurus Bio on 15 Jun 2026, and NextRNA Therapeutics on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy